SCHEMBL30457568

SCHEMBL30457568

C#Cc1ccc(C=C2C(=O)NC(=S)N(c3cccc(C(F)(F)F)c3)C2=O)o1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 12/20 0.56
KMT2A Q03164 12/20 0.56
L3MBTL1 Q9Y468 3/20 0.56
POLB P06746 8/20 0.53
GAA P10253 5/20 0.53
MAPT P10636 3/20 0.48
ALDH1A1 P00352 2/20 0.48
RECQL P46063 2/20 0.48
HTT P42858 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
DUSP3 P51452 2/20 0.48
BLM P54132 3/20 0.46
DNMT1 P26358 2/20 0.46
USP2 O75604 2/20 0.46
BRAF P15056 5/20 0.46
HPGD P15428 1/20 0.46
ALOX12 P18054 1/20 0.46
NSD2 O96028 1/20 0.45
CTDSP1 Q9GZU7 1/20 0.45
PPP1CA P62136 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25633601 1.00 MEN1 (0.56) MEN1KMT2AL3MBTL1POLBGAA
SCHEMBL25230974 0.91 MEN1 (0.50) MEN1KMT2AL3MBTL1POLBGAA
SCHEMBL25633608 0.91 MEN1 (0.50) MEN1KMT2AL3MBTL1POLBGAA
SCHEMBL25633584 0.87 MEN1 (0.73) MEN1KMT2AL3MBTL1POLBGAA
SCHEMBL30457573 0.87 MEN1 (0.73) MEN1KMT2AL3MBTL1POLBGAA
SCHEMBL25633583 0.85 MEN1 (0.64) MEN1KMT2AL3MBTL1POLBGAA
SCHEMBL25271929 0.85 MEN1 (0.64) MEN1KMT2AL3MBTL1POLBGAA
SCHEMBL30457579 0.84 MEN1 (0.75) MEN1KMT2AL3MBTL1POLBGAA
SCHEMBL25633596 0.84 MEN1 (0.75) MEN1KMT2AL3MBTL1POLBGAA
SCHEMBL25633592 0.81 KMT2A (0.71) MEN1KMT2AL3MBTL1POLBGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250051314-A1 SMALL MOLECULE INHIBITORS OF INTERFERON GAMMA SIGNALING PARIS SCIENCES ET LETTRES (FR) 2025-02-13 US disclosed
EP-4444308-A1 SMALL MOLECULE INHIBITORS OF INTERFERON GAMMA SIGNALING Institut Curie (FR) 2024-10-16 EP disclosed
WO-2023104976-A1 SMALL MOLECULE INHIBITORS OF INTERFERON GAMMA SIGNALING INSTITUT CURIE (FR) 2023-06-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250051314-A1 SMALL MOLECULE INHIBITORS OF INTERFERON GAMMA SIGNALING STAT1, IFNG, IRF2BP2 MEN1 3227/4885KMT2A 2840/4885L3MBTL1 4314/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.